Search - tctmd.com

Displaying 441 - 460 of 571

Sort: Relevancy | Date

Presentation TCT 2013

FFR in Patients with Acute Coronary Syndromes

Presenter: Habib Samady

October 30, 2013

Presentation TCT 2013

FFR in Non-Left Main Bifurcation Lesions

Presenter: Bon-Kwon Koo

October 30, 2013

Presentation TCT 2013

FFR in Left Main Disease

Presenter: Andy Yong

October 30, 2013

Presentation TCT 2013

FFR Clinical Trials: Review and Update

Presenter: William Fearon

October 30, 2013

Presentation TCT 2013

ADVISE II: A Prospective, Registry Evaluation of iFR vs. FFR

Presenter: Javier Escaned

October 30, 2013

News Conference News TCT 2013

Novel Ischemia Measurement Strategies Show Potential vs. FFR

October 30, 2013

Presentation TCT 2013

What would an outcomes trial comparing FFR for all lesions versus a hybrid approach (resting index plus selective FFR) look like?

Presenter: Nils P. Johnson

October 29, 2013

Presentation TCT 2013

TCT-80. Applicability of hybrid strategy (resting index plus selective FFR) to assess hemodynamic significance of coronary stenoses depends on FFR distribution

Presenter: Nils Johnson

October 29, 2013

Presentation TCT 2013

TCT-77. Safety of provocative tests to detect coronary artery spasm. Results from a French registry including 2,430 patients.

Presenter: Olivier Varenne

October 29, 2013

Presentation TCT 2013

How Do I Identify a Culprit Lesion?

Presenter: Takashi Kubo

October 29, 2013

Presentation TCT 2013

TCT-84. Fractional Flow Reserve versus Angiography in Guiding Management to Optimize Outcomes in Non-ST Elevation Myocardial Infarction (FAMOUS – NSTEMI) Clinical Trial: Study...

Presenter: Colin Berry

October 29, 2013

Presentation TCT 2013

TCT-83. Risk Model for Estimating the One-Year Risk of Deferred Lesion Intervention Following Deferred Revascularization after Fractional Flow Reserve Assessment

Presenter: Jeremiah Depta

October 29, 2013

Presentation TCT 2013

TCT-82. Fractional Flow Reserve versus Angiography in Guiding Management to Optimize Outcomes in Non-ST Elevation Myocardial Infarction (FAMOUS – NSTEMI) Clinical Trial:...

Presenter: Colin Berry

October 29, 2013

Presentation TCT 2013

TCT-81. Doppler-flow and pressure derived hyperemic microvascular resistance measurements predict abnormal H[sub]2[/sub][sup]15[/sup]O PET-quantified myocardial blood flow after...

Presenter: Guus Waard

October 29, 2013

Presentation TCT 2013

TCT-76. Does Age Affect Fractional Flow Reserve-Guided Percutaneous Coronary Intervention? A FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) Trial...

Presenter: Hong-Seok Lim

October 29, 2013

Presentation TCT 2013

Single Bolus Regadenoson Injection Versus Central Venous Infusion Of Adenosine To Induce Maximum Coronary Hyperemia For Measurement Of FFR

Presenter: Lokien X. van Nunen

October 29, 2013

Presentation TCT 2013

How Do I Assess an Intermediate Lesion?

Presenter: William Fearon

October 29, 2013

Presentation TCT 2013

Do We Need a Trial of FFR-Guided Surgical Revascularization? The CTSN Network Proposal

Presenter: Michael Argenziano

October 29, 2013

Presentation TCT 2013

Prognostic Implications of Quantitative Ischemia in Stable Ischemic Heart Disease: Lessons from SPECT, PET, and FFR

Presenter: Leslee Shaw

October 28, 2013

Presentation TCT 2013

FFR is Physiologic, and We Have the Data!

Presenter: Michalis Hamilos

October 28, 2013

Advertisement

FFR in Patients with Acute Coronary Syndromes

FFR in Non-Left Main Bifurcation Lesions

FFR in Left Main Disease

FFR Clinical Trials: Review and Update

ADVISE II: A Prospective, Registry Evaluation of iFR vs. FFR

Novel Ischemia Measurement Strategies Show Potential vs. FFR

What would an outcomes trial comparing FFR for all lesions versus a hybrid approach (resting index plus selective FFR) look like?

TCT-80. Applicability of hybrid strategy (resting index plus selective FFR) to assess hemodynamic significance of coronary stenoses depends on FFR distribution

TCT-77. Safety of provocative tests to detect coronary artery spasm. Results from a French registry including 2,430 patients.

How Do I Identify a Culprit Lesion?

TCT-84. Fractional Flow Reserve versus Angiography in Guiding Management to Optimize Outcomes in Non-ST Elevation Myocardial Infarction (FAMOUS – NSTEMI) Clinical Trial: Study...

TCT-83. Risk Model for Estimating the One-Year Risk of Deferred Lesion Intervention Following Deferred Revascularization after Fractional Flow Reserve Assessment

TCT-82. Fractional Flow Reserve versus Angiography in Guiding Management to Optimize Outcomes in Non-ST Elevation Myocardial Infarction (FAMOUS – NSTEMI) Clinical Trial:...

TCT-81. Doppler-flow and pressure derived hyperemic microvascular resistance measurements predict abnormal H[sub]2[/sub][sup]15[/sup]O PET-quantified myocardial blood flow after...

TCT-76. Does Age Affect Fractional Flow Reserve-Guided Percutaneous Coronary Intervention? A FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) Trial...

Single Bolus Regadenoson Injection Versus Central Venous Infusion Of Adenosine To Induce Maximum Coronary Hyperemia For Measurement Of FFR

How Do I Assess an Intermediate Lesion?

Do We Need a Trial of FFR-Guided Surgical Revascularization? The CTSN Network Proposal

Prognostic Implications of Quantitative Ischemia in Stable Ischemic Heart Disease: Lessons from SPECT, PET, and FFR

FFR is Physiologic, and We Have the Data!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content